A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500 in Healthy Subjects

Clinical trial NCT07473752 · COMPLETED

Trial details

NCT number: NCT07473752
Sponsor: Tonix Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Phase 1 First-in-human Study Involving Healthy Subjects

Start date: 2023-07-18
Primary completion: 2024-02-22
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.